The trademark DERMAMAX was filed by DOMAX Medicare Inc., a corporation established under the laws of the Republic of Korea (the "Applicant") and Jong Min Park, a national of the Republic of Korea (the "Co-Applicant", and jointly with the "Applicant" referred to as the "Applicants" going forward). The application was published for oppositions on July 18, 2021, and received one opposition filed on October 13, 2021 by OMEGA PHARMA INNOVATION & DEVELOPMENT NV on Likelihood of confusion. the opponent was represented by FENCER and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 13, 2021
The application was filed in English, and English was also language of all opposition proceedings (German was selected as the second language).
The Opposition with reference B 003156662 was refused according to Article 8(1)(b) EUTMR with decision issued on November 30, 2022 by the EUIPO.